From: Excellent survival of pathological N0 small cell lung cancer patients following surgery
Characteristics | N = 196(%) |
---|---|
Age, median(range) | 63(36–84) |
Gender, N(%) | |
Male | 167(85.2) |
Female | 29(14.7) |
Respiratory risk, n (%) | |
Active smoker | 149(76.0) |
Never smoker | 47(23.9) |
Cancer description | |
Median size cm (min–max) | 2.8(0.7–11.2) |
Surgery, n(%) | |
Video-assisted thoracoscope surgery | 47(23.9) |
Thoracotomy | 149(76.0) |
Range of resection, n (%) | |
PNEUM | 10(5.1) |
SLE | 3(1.5) |
BILOB | 20(10.2) |
LOB | 144(73.4) |
SEG | 10(5.1) |
WED | 9(4.5) |
pT staging, n (%) | |
pT1 | 105(53.6) |
pT2 | 67(34.2) |
pT3 | 19(9.7) |
pT4 | 5(2.6) |
pN staging, n (%) | |
pN0 | 95(48.5) |
pN1 | 36(18.4) |
pN2 | 65(33.2) |
pTNM staging, n (%) | |
IA | 65(33.2) |
IB | 17(8.7) |
IIA | 6(3.1) |
IIB | 39(19.9) |
IIIA | 54(27.6) |
IIIB | 15(7.6) |
cT staging, n (%) | |
pT1 | 104(53.1) |
pT2 | 53(27.0) |
pT3 | 14(7.1) |
pT4 | 6(3.1) |
Unknown | 19(9.7) |
cN staging, n (%) | |
pN0 | 86(43.9) |
pN1 | 37(18.9) |
pN2 | 54(27.6) |
Unknown | 19(9.7) |
cTNM staging, n (%) | |
IA | 52(26.5) |
IB | 19(9.7) |
IIA | 6(3.1) |
IIB | 39(19.9) |
IIIA | 56(28.6) |
IIIB | 5(2.6) |
Unknown | 19(9.7) |
Postoperative therapy | |
Non-adjuvant therapy | 58(29.6) |
Adjuvant chemotherapy | 75(38.3) |
Adjuvant chemoradiotherapy | 63(32.1) |
Time from diagnosis to surgery (days) | 30(5–719) |
BMI(kg/m2) | 24.2(17.0–35.3) |
ECOG score | |
1 | 16 |
0 | 180 |